glp 1 from china More Chinese biotechs challenge GLP-1 dominance in diabetes GLP-1 Agonists Market Report 2025-2033,

Contemporary evidence has established a clear efficacy hierarchy among agents, with dual and triple receptor agonists demonstrating superior outcomes compared to traditional GLP-1 monotherapy (Table 4)

GI Society

As a result, many such peptides remain underexplored despite extensive biological validation

Further, a majority of the sample (82.6%) was White/Caucasian, and 80% of participants reported that GLP-1RA use resulted in greater weight loss than conventional programs

It was almost as good as the injectable semaglutide, though, Gokhale says

Shapely is a personalized weight loss program in Santa Ana, California that takes a whole-person approach to losing weight and keeping it off